Bioxyne (ASX:BXN) Other Operating Expense : A$1.63 Mil (TTM As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Bioxyne Other Operating Expense?

Bioxyne's Other Operating Expense for the six months ended in Dec. 2024 was A$0.93 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was A$1.63 Mil.

Bioxyne's quarterly Other Operating Expense declined from Dec. 2023 (A$1.38 Mil) to Jun. 2024 (A$0.69 Mil) but then increased from Jun. 2024 (A$0.69 Mil) to Dec. 2024 (A$0.93 Mil).

Bioxyne's annual Other Operating Expense increased from Jun. 2022 (A$0.64 Mil) to Jun. 2023 (A$1.61 Mil) but then declined from Jun. 2023 (A$1.61 Mil) to Jun. 2024 (A$1.36 Mil).

Bioxyne Other Operating Expense Historical Data

The historical data trend for Bioxyne's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioxyne Other Operating Expense Chart

Bioxyne Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Operating Expense

Get a 7-Day Free Trial

0.68

0.51

0.64

1.61

1.36

Bioxyne Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Operating Expense	Get a 7-Day Free Trial															0.31	1.30	1.38	0.69	0.93

Bioxyne Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$1.63 Mil.

Bioxyne Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Bioxyne's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioxyne Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bioxyne Ltd (ASX:BXN) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000

Website

https://www.bioxyne.com

Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus fermentum PCC. Some of its products include Breathe Life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange, and others. The company operates in segments namely, wholesale sales, Plant-based, Manufacturing sales, and direct sales. The majority of the revenue is generated from plants based segment.

Bioxyne Headlines

No Headlines